Takeshi Yamada, Professor from Daiichi Institute of Technology, describes the algorithm “DPTM” for continuous authentication with behavioural biometrics, beginning with the current device security outlook. Cyberattacks and cybercrimes increase every year. Under such a scenario, the user’s need for security enhancement is urgent. Looking at current user authentication, most are authenticated only at the login stage, with ID and password, biometrics, or other forms.
日本第一工业大学（Daiichi Institute of Technology）教授山田武（Takeshi Yamada）从当前设备安全的前景入手，介绍了利用行为生物识别技术进行连续身份验证的算法 "DPTM"。网络攻击和网络犯罪每年都在增加。在这种情况下，用户对提高安全性的需求十分迫切。纵观当前的用户身份验证，大多数都是在登录阶段通过 ID 和密码、生物识别或其他形式进行身份验证。
{"title":"Algorithm “DPTM” for continuous authentication with behavioural biometrics","authors":"Takeshi Yamada","doi":"10.56367/oag-043-11458","DOIUrl":"https://doi.org/10.56367/oag-043-11458","url":null,"abstract":"\u0000 \u0000 Takeshi Yamada, Professor from Daiichi Institute of Technology, describes the algorithm “DPTM” for continuous authentication with behavioural biometrics, beginning with the current device security outlook. Cyberattacks and cybercrimes increase every year. Under such a scenario, the user’s need for security enhancement is urgent. Looking at current user authentication, most are authenticated only at the login stage, with ID and password, biometrics, or other forms.\u0000","PeriodicalId":475859,"journal":{"name":"Open Access Government","volume":" 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141670445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
John H. Miller, Jr., University of Houston (UH), from the Dept. of Physics and Texas Center for Superconductivity, explains collective quantum phenomena and their applications. The evidence supporting the quantum behavior of electrons, as well as every other known particle in the universe, is overwhelming. On the centennial anniversary of Max Planck’s seminal paper on energy quantization (1), Kleppner and Jackiw pointed out, “Quantum theory is the most precisely tested and most successful theory in the history of science”. (2)
休斯顿大学（UH）物理系和德克萨斯超导中心的小约翰-米勒（John H. Miller）解释了集体量子现象及其应用。支持电子以及宇宙中所有其他已知粒子的量子行为的证据是压倒性的。在马克斯-普朗克（Max Planck）关于能量量子化的开创性论文(1)发表一百周年之际，Kleppner 和 Jackiw 指出："量子理论是科学史上经过最精确检验和最成功的理论"。(2)
{"title":"Collective quantum phenomena and their applications","authors":"John H Miller","doi":"10.56367/oag-043-11330","DOIUrl":"https://doi.org/10.56367/oag-043-11330","url":null,"abstract":"\u0000 \u0000 John H. Miller, Jr., University of Houston (UH), from the Dept. of Physics and Texas Center for Superconductivity, explains collective quantum phenomena and their applications. The evidence supporting the quantum behavior of electrons, as well as every other known particle in the universe, is overwhelming. On the centennial anniversary of Max Planck’s seminal paper on energy quantization (1), Kleppner and Jackiw pointed out, “Quantum theory is the most precisely tested and most successful theory in the history of science”. (2)\u0000","PeriodicalId":475859,"journal":{"name":"Open Access Government","volume":"122 32","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141667600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Two seasoned experts from CPI, Medicines Manufacturing Innovation Centre, detail how the “tides” have turned in pharma manufacturing. Oligonucleotides and peptides are two of the fastest-growing pharmaceutical drug modalities with the potential to revolutionise the treatment of many human diseases. The incredible demand for new type II diabetes and obesity peptide therapies recently launched by Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide) and the acceleration in approvals of oligonucleotide therapies make them a hot topic in the pharmaceutical world.
来自 CPI（药品制造创新中心）的两位资深专家详细介绍了制药业的 "潮汐 "是如何转向的。寡核苷酸和多肽是增长最快的两种药物模式，有可能彻底改变许多人类疾病的治疗方法。诺和诺德（semaglutide）和礼来（tirzepatide）最近推出的新型 II 型糖尿病和肥胖症多肽疗法需求量惊人，寡核苷酸疗法的审批速度也在加快，这使它们成为制药界的热门话题。
{"title":"How the “tides” have turned in pharma manufacturing","authors":"Deborah McElhone, Barrie Cassey","doi":"10.56367/oag-043-11453","DOIUrl":"https://doi.org/10.56367/oag-043-11453","url":null,"abstract":"\u0000 \u0000 Two seasoned experts from CPI, Medicines Manufacturing Innovation Centre, detail how the “tides” have turned in pharma manufacturing. Oligonucleotides and peptides are two of the fastest-growing pharmaceutical drug modalities with the potential to revolutionise the treatment of many human diseases. The incredible demand for new type II diabetes and obesity peptide therapies recently launched by Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide) and the acceleration in approvals of oligonucleotide therapies make them a hot topic in the pharmaceutical world.\u0000","PeriodicalId":475859,"journal":{"name":"Open Access Government","volume":" 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141670029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Susana Soares, Rosa Pérez-Gregorio, Rita Vilaça, Susana M.P Carvalho, T. Izsó, G. Kasza
Researchers from the WHEATBIOME project joined forces to address several challenges related to sustainable wheat production and consumption, revealing the role of microbes in shaping the Future of Healthy Food. Food systems are facing unprecedented challenges due to the increase in the world population, climate change, and geopolitical instability, which threaten food security and prices. Additionally, systemic inefficiencies and massive food waste from crop harvest to consumption have been observed. This scenario imposes an urgent unification of different scientific research areas to advance knowledge on a future-proof agrifood system. Wheat is a staple crop facing stagnant production in Europe due to increasing biotic and abiotic stresses exacerbated by climate change. Its nutritional importance spans human and animal consumption, yet its immunogenicity poses health risks like gluten sensitivity and celiac disease.
{"title":"Microbiomes for the future of sustainable wheat production","authors":"Susana Soares, Rosa Pérez-Gregorio, Rita Vilaça, Susana M.P Carvalho, T. Izsó, G. Kasza","doi":"10.56367/oag-043-11507","DOIUrl":"https://doi.org/10.56367/oag-043-11507","url":null,"abstract":"\u0000 \u0000 Researchers from the WHEATBIOME project joined forces to address several challenges related to sustainable wheat production and consumption, revealing the role of microbes in shaping the Future of Healthy Food. Food systems are facing unprecedented challenges due to the increase in the world population, climate change, and geopolitical instability, which threaten food security and prices. Additionally, systemic inefficiencies and massive food waste from crop harvest to consumption have been observed. This scenario imposes an urgent unification of different scientific research areas to advance knowledge on a future-proof agrifood system. Wheat is a staple crop facing stagnant production in Europe due to increasing biotic and abiotic stresses exacerbated by climate change. Its nutritional importance spans human and animal consumption, yet its immunogenicity poses health risks like gluten sensitivity and celiac disease.\u0000","PeriodicalId":475859,"journal":{"name":"Open Access Government","volume":" 394","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141669621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Professor Shaw-Ruey Lyu from the Dalin Tzu-Chi Hospital discusses the benefits of arthroscopic cartilage regeneration facilitating procedure (ACRFP) as an alternative to traditional methods of treating knee OA. I have always been a conscientious orthopedic surgeon. I was trained in mainstream orthopedic medicine and had treated many patients suffering from knee osteoarthritis (knee OA) with all the available tools in the ‘mainstream medicine’ repertoire (Table 1). Traditional treatment often led patients to eventual knee replacement. That is proof that mainstream medicine cannot stop knee OA from deteriorating, and even lead to patients needing a knee replacement.
大林慈济医院的柳绍瑞教授探讨了关节镜下软骨再生促进术（ACRFP）替代传统方法治疗膝关节OA的益处。我一直是一名认真负责的骨科医生。我接受过主流骨科医学的培训，曾用 "主流医学 "的所有可用工具治疗过许多膝关节骨性关节炎（膝关节 OA）患者（表 1）。传统治疗往往导致患者最终接受膝关节置换术。这证明主流医学无法阻止膝关节 OA 的恶化，甚至会导致患者需要进行膝关节置换。
{"title":"A wonder therapy for knee osteoarthritis","authors":"S. Lyu","doi":"10.56367/oag-041-10914","DOIUrl":"https://doi.org/10.56367/oag-041-10914","url":null,"abstract":"\u0000 \u0000 Professor Shaw-Ruey Lyu from the Dalin Tzu-Chi Hospital discusses the benefits of arthroscopic cartilage regeneration facilitating procedure (ACRFP) as an alternative to traditional methods of treating knee OA. I have always been a conscientious orthopedic surgeon. I was trained in mainstream orthopedic medicine and had treated many patients suffering from knee osteoarthritis (knee OA) with all the available tools in the ‘mainstream medicine’ repertoire (Table 1). Traditional treatment often led patients to eventual knee replacement. That is proof that mainstream medicine cannot stop knee OA from deteriorating, and even lead to patients needing a knee replacement.\u0000","PeriodicalId":475859,"journal":{"name":"Open Access Government","volume":"29 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140498053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：